Factor VII Deficiency
9 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders (NCT04548791) | Catalyst Biosciences | 2021-05-17 |
| Early Check: Expanded Screening in Newborns (NCT03655223) | RTI International | 2018-10-15 |
| Study Comparing the Pharmacokinetic of Biosimilar Eptacog Alfa With Novoseven®, in Patients With Congenital Factor VII Deficiency (NCT03079063) | AryoGen Pharmed Co. | 2017-03-01 |
| Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven (NCT03372993) | AryoGen Pharmed Co. | 2016-06-13 |
| Treatment of Inherited Factor VII Deficiency (NCT01269138) | University of L'Aquila | 2007-01-01 |
Track Factor VII Deficiency automatically
Every clearance here is in the API, with alerts when new ones post.